Search clinical trials for: Dipeptidyl peptidase-4 (DPP-4) inhibitors
Total 2576 results
-
PfizerCompletedVenous ThrombosisAustralia, United States, Spain, Czech Republic, Portugal, Canada, South Africa, Italy, Colombia, Poland, France, Chile, Russian Federation, Denmark, United Kingdom, Slovakia
-
Sierra Oncology LLC - a GSK companyCompletedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisKorea, Republic of, Canada, Hungary, Israel, Spain, United States, Australia, Taiwan, Singapore, Germany, Italy, France, Belgium, New Zealand, Austria, United Kingdom, Denmark, Bulgaria, Poland, Czechia, Romania, Sweden
-
Novartis PharmaceuticalsCompletedDiabetes | Renal ImpairmentRussian Federation
-
NovartisCompletedDiabetes Mellitus, Type 2Japan
-
NovartisCompletedDiabetes Mellitus, Type 2Japan
-
NovartisCompleted
-
MTI UniversityNational Institute of Diabetes and Endocrinology, EgyptRecruitingType 2 Diabetes MellitusEgypt
-
University Malaysia SarawakSarawak General HospitalCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
Medical University of ViennaCompleted
-
GlaxoSmithKlineCompletedAsthma | Mild AsthmaUnited Kingdom
-
Spectrum Health HospitalsHelen DeVos Children's HospitalCompleted
-
Eisai Inc.CompletedEwing Sarcoma | Rhabdomyosarcoma | Refractory or Recurrent Solid Tumors | Non-Rhabdomyosarcoma Soft Tissue SarcomaSpain, United Kingdom, Italy, France, Germany, Greece, Poland, Switzerland
-
NovartisCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusUnited Kingdom, Belgium, Bulgaria, Spain, Slovakia, Germany, Finland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Daniel Hägi-PedersenCopenhagen Trial Unit, Center for Clinical Intervention ResearchCompletedPain, PostoperativeDenmark
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2Germany, United States
-
NovartisCompletedDiabetes Mellitus, Type 2
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Tang-Du HospitalNot yet recruitingSpontaneous Subarachnoid Hemorrhage
-
Seattle Children's HospitalActive, not recruitingMelanoma | Soft Tissue Sarcoma | Carcinoma | Osteosarcoma | Ewing Sarcoma | Rhabdoid Tumor | Neuroblastoma | Retinoblastoma | Rhabdomyosarcoma | Wilms Tumor | Hepatoblastoma | Synovial Sarcoma | Desmoplastic Small Round Cell Tumor | Germ Cell Tumor | Pediatric Solid Tumor | Clear Cell Sarcoma | Malignant Peripheral Nerve Sheath...United States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
NovartisCompletedType 2 Diabetes MellitusGermany, Romania, Hungary, Belgium, Slovakia, Australia, India, Czech Republic, Guatemala, Hong Kong, United Kingdom
-
NovartisCompletedVildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Germany
-
Novartis PharmaceuticalsCompletedEfficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 DiabetesDiabetes Mellitus, Type 2Switzerland
-
NovartisCompletedPrediabetic StateUnited States
-
NovartisCompletedType 2 Diabetes MellitusGermany
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Otsuka America PharmaceuticalCompletedAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Nicolaas Bohnen, MD, PhDNational Institute of Neurological Disorders and Stroke (NINDS)CompletedParkinson DiseaseUnited States
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
Royal Devon and Exeter NHS Foundation TrustNovartis Pharmaceuticals; National Institute for Health Research, United KingdomCompletedInsulin Resistance | Microvascular DiseaseUnited Kingdom
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusEgypt
-
University of Campania "Luigi Vanvitelli"CompletedChronic Foot UlcersItaly
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusUnited Kingdom
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
GlaxoSmithKlineCompletedAsthmaNew Zealand, South Africa
-
SanofiTerminated
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
NovartisTerminatedDiabetes Mellitus, Type 2United States